Statins Boost Abiraterone Activity in Prostate Cancer

Statins Boost Abiraterone Activity in Prostate Cancer

SAN FRANCISCO ― Statin use may prolong the duration of abiraterone acetate (Zytiga, Janssen Pharmaceuticals, Inc) treatment in men with castration-resistant prostate cancer (CRPC), according to new findings presented here at Genitourinary Cancers …

(Visited 2 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.